Research director, leader of the team "RhoGTPases in osteoclast biology" at CNRS in Montpellier, France. Genreal secretary of the French Society for Cell Biology SBCF.
Professor of Medicine and Preventive Medicine, Feinberg School of Medicine, Northwestern University. Fellow of the Gerontology Society of America.
Research Assistant Professor, Northwestern University Feinberg School of Medicine; Past-President Association of Rheumatology Health Professionals
Group Leader in Arthritis and Lupus Research Group, Department of Medicine, Monash University.
Senior lecturer psychology at the University of Portsmouth. Before that group leader of the group “Evolutionary Roots of Human Social Interaction” at the Max Planck Institute EVAN Germany. Junior Research Fellow at Churchill College and a member of the Experimental Psychology lab of Cambridge University.
Main research interest is the evolution of human sociality. Special interest in ToM, cooperation and communication among individuals.
Sandra Kleinau obtained her Ph.D. in clinical immunology from Uppsala University (UU), Sweden and performed postdoctoral studies at Karolinska Institute in Stockholm and later at UU. She established her own research group in 1997, received a permanent position at UU in 2004 and became Professor of Biology in 2008. Dr Kleinau has a research interest in autoimmunity, particularly autoimmune arthritis, with focus on exploiting B cells, antibodies, Fc receptors and complement.
Professor of Experimental Rheumatology University Medical Centre Utrecht. Manager of research and head of research laboratory of the department of Rheumatology & Clinical Immunology, UMCU. In addition to organization, initiation, and facilitation research of the department, there is a personal interest in a unique treatment of severe osteoarthritis being joint distraction, and in a unique animal model of osteoarthritis being the canine Groove model.
Academic Editor PLoS ONE. Recipient of the 2006 Rupert Timpl Award from the International Society for Matrix Biology.
Full professor of Orthopedics and Preventive Medicine in Faculty of Nursing and Podiatry. Universidade da Coruña, Spain.
Also is director in the Research, Health and Podiatry Unit. Department of Health Sciences. Faculty of Nursing and Podiatry. Universidade da Coruña, Spain.
Dr. Kutty Selva Nandakumar (h-index: 33) is Professor of Pharmacology in the School of Pharmaceutical Sciences, Guangzhou, China. He is an international scientist and has 27 years of research experience from three different countries (India, Sweden and China). He has research experience in Rheumatology, Tumor Immunology and Salmonellosis/Typhoid Fever.
- 1988 Medical Degree
- 1991 Project Research performed abroad Italy. University of Umeå, Sweden
- 1993 Italian Ph.D. in Experimental Medicine, University of Perugia
- 1997 Specialisation in Clinical Pathology, Perugia University Medical School
- 2000-2006 Researcher,
- 2006-present. Associate Professor. University of Perugia.
- 2001-2006: Chair of Pharmacology, School of Motor and Sport Sciences, University of Perugia.
- 2006-present: Chair of Pharmacology, Medical School. University of Perugia.
- 2015-present: Coordinator of PhD School on "Pharmacological Biotecnology and Clinical Pharmacology”, University of Perugia
- Member of the "Italian Society of Pharmacology" (SIF)
- Member of the “European Academy of Sciences and Arts”
PUBLICATIONS AND METRICS
Publications in peer reviewed international journals: 91
Carlo Pucillo is full professor in Immunology at School of Medicine of University of Udine. In his scientific career Prof. Carlo Pucillo has studied the "non canonical function" of MHC class II and the molecular mechanism that regulate the B cell activation and differentiation. From 2-1991 to 6-1994 Dr Pucillo has been Visiting Scientist at NCI in Bethesda, MD-USA.
He has acquired a considerable expertise in advanced molecular biology analysis as well as a good understanding of the immunobiology of the immune response, of the non canonical function of MHC class II molecules, in particular, as documented by his publications on this subjects.
He has also investigated the signal transduction pathways elicited by T-B cell interaction via CD40-CD154. CD40 is a B cell surface receptor that belongs to the pleiotropic tumor necrosis factor receptor (TNFR) superfamily. The interaction between CD40 and its ligand promotes proliferation, cytokine production, upregulation of various surface molecules involved in antigen presentation, germinal center and memory B cell formation antibody isotype switching and affinity maturation and the B cell life span.
Most recently, his interest is in the study of regulatory role of Mast Cells in the microenvironment and subsequently in the tissutal tolerance and adaptive immune response. This body of work may provide a conceptual framework to therapeutically manipulate these responses in the settings of autoimmune disease and cancer.